We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK PAYS NEW YORK $2.5 MILLION TO SETTLE PAXIL SUIT
GSK PAYS NEW YORK $2.5 MILLION TO SETTLE PAXIL SUIT
August 26, 2004
GlaxoSmithKline (GSK) has agreed to pay the state of New York $2.5 million to settle litigation related to the disclosure of data on the use of Paxil in children and adolescents with depression.